|
Pten
There is as yet no good drug to target the PTEN pathway. Velcade is not a good drug for this pathway as it really targets a protein degradeation pathway
mediated throught the endosome in the cell. There is a connection however it is tangential, between these pathways but it is far too tenuous to make a therapeutic decision. Moreover, the data are not at all clear that the PTEN alteration plays a direct role in HER2 positive tumors. There is no need for PTEN
testing at this point in time and it would not alter a treatment plan.
Hope this helps!
Jean
|